Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression

Journal of Neuroscience Research

Volumn 60, Issue 6, 2000, Pages 767-778

  Ahlemeyer, Barbara ^a   Hühne, Ricarda ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Alzheimer disease; Apoptosis; Neuron; NGF; Retinoic acid; Staurosporine; TrkA

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR RECEPTOR TRKA; RETINOIC ACID; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CHICK EMBRYO; CONTROLLED STUDY; DRUG PENETRATION; DRUG POTENTIATION; EMBRYO; GROWTH STIMULATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0343293791     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20000615)60:6<767::AID-JNR9>3.0.CO;2-6     Document Type: Article

References (67)

1. Ahlemeyer B, Krieglstein J. 1998. Retinoic acid reduces staurosporine-induced apoptotic damage in chick embryonic neurons by suppressing reactive oxygen species production. Neurosci Lett 246:93-96.
2. Anderson CNG, Tolkovsky AM. 1999. A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinofuranoside. J Neurosci 19:664-673.
3. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrhenius S, Lipton SA, Nicotera P. 1995. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-973.
4. Backman C, Rose GM, Hoffer BJ, Henry MA, Bartus RT, Friden P, Granholm AC. 1996. Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J Neurosci 16:5437-5442.
5. Barbacid M. 1994. The trk family of neurotrophin receptors. J Neurobiol 25:1386-1403.
6. Barinaga M. 1998. Stroke-damaged neurons may commit cellular suicide. Science 281:1301-1303.
7. Bergman E, Fundin BT, Ulfhake B. 1999. Effects of aging and axotomy on the expression of neurotrophin receptors in primary sensory neurons. J Comp Neurol 410:368-386.
8. Bertrand P, Roger O, Houlgatte R, Javoy-Agid JP, Brandel A, Doble A, Blanchard JC. 1992. Measurement of nerve growth factor-like immunoreactivity in the human brain using an anti-mouse-NGF enzyme immunoassay. Neurochem Int 20:215-218.
9. Boniece IR, Wagner A. 1995. NGF protects PC12 cells against ischemia by a mechanism that requires the N-kinase. J Neurosci Res 40:1-9.
10. Bossiere F, Faucheux B, Ruberg M, Agid Y, Hirsch EC. 1997. Decreased trkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer disease. Exp Neurol 145:245-255.
11. Carswell S. 1993. The potential for treating neurodegenerative disorders with NGF-inducing compounds. Exp Neurobiol 124:36-42.
12. Charles V, Mufson EJ, Friden P, Bartus RT, Kordower JH. 1996. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Res 728:193-203.
13. Cheung WMW, Chu AH, Leung MF, Nancy YI. 1996. Induction of trk receptors by retinoic acid in a human embryonal carcinoma cell line. NeuroReport 7:1204-1208.
14. Cheung NS, Pascoe CJ, Giardina SF, John CA, Beart PM. 1998. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones. Neuropharmacology 37:1419-1429.
15. 125J]nerve growth factor by cholinergic neurons and down-regulated trkA expression in the medial septum of aged rats. Neuroscience 62:625-629.
16. Corcoran J, Madsen M. 1999. Nerve growth factor acts via retinoic acid synthesis to stimulate neunte outgrowth. Nature Neurosci 2:307-308.
17. Culmsee C, Semkova I, Krieglstein J. 1999. NGF mediates the neuroprotective effect of the β2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from a NGF-antisense study. Neurochem Int 35:47-57.
18. de The H, del Mar Vicano-Ruiz M, Tiollais P, Stunnenberg H, Dejean A. 1990. The t(15;17) translocation of acute promyelotic leukemia fuses the retinoic acid receptor alpha genes to a novel transient locus. Nature 343:177-180.
19. Dollé P, Fraulob V, Kastner P, Chambon P. 1994. Developmental expression of murine retinoic X receptor (RXR) genes. Mech Dev 45:91-104.
20. Dugan LL, Creedon DJ, Johnson Jr EM, Holtzman DM. 1997. Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:4086-4091.
21. Flicker SH, Schneider SM, Offterdinger M, Dittrich E, Fazeny B, Valenta R, Huber H, Dittrich C, Grunt TW. 1997. Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-α in SK-BR-3 breast cancer cells. Cancer Lett 115: 63-72.
22. Franklin JL, Johnson EM. 1998. Control of neuronal size homeostasis by trophic factor mediated coupling of protein degradation to protein synthesis. J Cell Biol 142:1313-1324.
23. Goedert M, Fine A, Dawbarn D, Wilcock GK, Chao MV. 1989. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer disease. Brain Res Mol Brain Res 5:1-7.
24. Haviv R, Stein R. 1999. Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells. J Neurosci Res 55:269-277.
25. Hefti F. 1999. Nerve growth factor treatment for Alzheimer disease: the experience of the first attempt at intracerebral neurotrophic factor therapy. In: Hefti I, editor. Neurotrophic factors. Handbook of Experimental Pharmacology, Vol. 134. Berlin, Heidelberg: Springer Verlag. p 176-187.
26. Hellweg R, Gericke CA, Jendroska K, Hartung HD, Cervosnavarro J. 1998. NGF content in the cerebral cortex of non-demented patients with amyloid plaques and in symptomatic Alzheimer disease. Int J Dev Neurosci 16:7-8.
27. Hock H, Heese K, Muller-Spahn F, Rosenberg C, Otten U. 1998. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer disease. Neurosci Lett 241:151-154.
28. Isaacson LG, Saffran BN, Crutcher KA. 1990. Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels. Neurobiol Aging 11:51-55.
29. 2-induced apoptosis in PC12 cells by glutathione independent mechanism. Neurosci Lett 21:179-182.
30. Kaplan DR, Miller FD. 1997. Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 9:213-221.
31. Katoh S, Mitsui Y, Kitani K, Suzuki T. 1997. The rescuing effect of nerve growth factor is the result of up-regulation of bcl-2 in hyperoxia-induced apoptosis of a subclone of pheochromocytoma cells, PC12h. Neurosci Lett 29:71-74.
32. Koh JY, Wie MB, Gwag BJ, Sensi SL, Canzoniero LMT, Demaro J, Csernansky C, Choi DW. 1995. Staurosporine-induced neuronal apoptosis. Exp Neurol 135:153-159.
33. Krekowski CA, Parhad IM, Clark AW. 1996. Attenuation and recovery of nerve growth factor receptor mRNA in dorsal root ganglion neurons following axotomy. J Neurosci Res 43:1-11.
34. Krieglstein J, Culmsee C, Zhu Y, Semkova I. 1999. Stimulation of β2-adrenoceptors induces nerve growth factor and inhibits apoptosis in rat brain after ischemia. In: Ito U, editor. Maturation phenomenon in cerebral ischemia III. Berlin, Heidelberg: Springer Verlag. p 123-129.
35. Krohn AJ, Preis E, Prehn JHM. 1998. Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. J Neurosci 15:8186-8197.
36. Krohn AJ, Wahlbrink T, Prehn JHM. 1999. Mitochondrial depolarization is not required for neuronal apoptosis. J Neurosci 19:7394-7404.
37. Krumin I, Guo Q, Mattson M. 1998. Calcium and reactive oxygen species mediate staurosponne-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res 51:293-308.
38. Lewin GR, Ritter AM, Mendell LM. 1993. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13:1903-1912.
39. Love JM, Gudas LJ. 1994. Vitamin A, differentiation and cancer. Curr Opin Cell Biol 6:825-831.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
41. Lucarelli E, Kaplan DR, Thiele CJ. 1995. Selective regulation of trkA and trkB receptors by retinoic acid and interferon-γ in human neuroblastoma cell lines. J Biol Chem 270:24725-24731.
42. MacManus JP, Rasquina, I, Black MA, Laferriere NB, Monette R, Walker T, Morley P. 1997. Glutamate-treated rat cortical neurons die in a way different from classical apoptosis induced by staurosporine. Exp Cell Res 233:310-320.
43. Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ. 1995. Expression of brain-derived neurotrophic factor and p145 trkB affect survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55:1798-1806.
44. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
45. Mearow KM, Kril Y. 1995. Anti-NGF treatment blocks the upregulation of NGF receptor mRNA expression associated with collateral sprouting of rat dorsal root ganglion neurons. Neurosci Lett 184:55-58.
46. Mufson EJ, Livine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. 1997. Reduction in p140-trkA receptor protein within the nucleus basalis and cortex in Alzheimer disease. Exp Neurol 146:91-103.
47. Pettmann B, Louis, JC, Sensenbrenner, MCL. 1979. Morphological and biochemical maturation of neurones cultured in the absence of glial cells. Nature 281:378-380.
48. Rodriguez-Tébar A, Rohrer H. 1991. Retinoic acid induced NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 112:813-820.
49. NTR affinity states is mediated by direct receptor interactions. Eur J Neurosci 10:890-898.
50. Ruberte E, Friedrich V, Chambon P, Morris-Kay G. 1993. Retinoic acid receptors and cellular retinoid binding proteins III: their differential transcript distribution during mouse nervous system development. Development 118:267-282.
51. Satoh T, Sakai N, Enokido Y, Uchiyama Y, Hatanaka H. 1996a. Free radical-independent protection by nerve growth factor and bcl-2 of PC12 cells from hydrogen peroxide-triggered apoptosis. J Biochem 120:540-546.
52. Satoh T, Sakai N, Enokido Y, Uchiyama Y, Hatanaka H. 1996b. Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells. Brain Res 733:9-14.
53. Semkova I, Culmsee C, Krieglstein J. 1996a. Neuroprotection caused by NGF and NGF-inducing drugs. In. Krieglstein J, editor. Pharmacology of cerebral ischemia 1996. Stuttgart: MedPharm Scientific Publishers. p 477-493.
54. Semkova I, Schilling M, Henrich-Noack P, Rami A, Krieglstein J. 1996b. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate toxicity in cultured hippocampal neurons by induction of NGF. Brain Res 717:44-54.
55. Semkova I, Wolz P, Schilling M, Krieglstein J. 1996c. Selegilin enhances NGF synthesis and protects central nervous system neurons from excitotoxic damage. Eur J Pharmacol 315:19-30.
56. Simeone A, Acampora D, Arcioni L, Andrews PW, Boncinelli E, Mavillo F. 1990. Sequential activation of Hox 2 homeobox genes by retinoic acid in human embryonal carcinoma cells. Nature 346:763-766.
57. Spear N, Estevez AG, Barbeito L, Beckman JS, Johnson GV. 1997. Nerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase. J Neurochem 69:53-59.
58. Stephens RM, Loeb DM, Copeland TD, Pawson T, Greene LA, Kaplan DR. 1994. Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ to mediate NGF responses. Neuron 12:691-705.
59. Takadera T, Ohyashiki T. 1998. Apoptotic cell death and CPP-32-like activation induced by thapsigargin and their prevention by nerve growth factor in PC12 cells. Biochim Biophys Acta 1401:63-71.
60. van Grunsven LA, Thomas A, Urdiales JL, Machenaud S, Choler P, Durand I, Rudkin B. 1996. Nerve growth factor-induced accumulation of PC12 cells expressing cyclin D1: evidence for a G1 phase block. Oncogene 12:855-862.
61. van Holst A, Rodriguez-Tèbar A, Michaille JJ, Dhouailly D, Bäckström A, Ebendal T, Rohrer H. 1995. Retinoic acid-mediated increase in trkA expression is sufficient to elicit NGF-dependent survival of sympathetic neurons. Mol Cell Neurosci 6:185-198.
62. van Holst A, Lefcort F, Rohrer H. 1997. TrkA expression levels of sympathetic neurons correlate with NGF-dependent survival during development and after treatment with retinoic acid. Eur J Neurosci 9:2169-2177.
63. Wang SY, LaRosa GJ, Gudas LJ. 1985. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells. Dev Biol 107: 75-86.
64. Wiesner DA, Dawson G. 1996. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J Neurochem 66:1418-1425.
65. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH. 1986. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 83:9231-9235.
66. Wion D, Houlgatte R, Barbot N, Barrand P, Dicou E, Brachet P. 1987. Retinoic acid increases the expression of NGF gene in mouse L cells. Biochem Biophys Res Comm 16:510-514.
67. Xie P, Cheung WMW, Ip FCF, Ip NY, Leung MF. 1997. Induction of trkA receptor by retinoic acid in leukemia cell lines. NeuroReport 8:1067-1070.